Qizheng Tibetan Medicine Wins “2014 Global Compact China Best Practice Case”

Release time:

2015-02-26 17:04

　　On February 10, the China Network of the UN Global Compact released the "2014 Best Practice Cases of the UN Global Compact in China." Tibet Qizheng Tibetan Medicine Co., Ltd. was honored alongside a total of 25 multinational and large state-owned enterprises, including BASF, Nestlé, China National Petroleum Corporation, State Grid, Huawei, and HNA Group.

　　As early as 2004, Qizheng Tibetan Medicine joined the United Nations Global Compact. Thanks to its practical explorations in promoting the development of the ethnic medicine industry and providing sustained support to Tibetan areas through long-term mechanisms, it was selected as a “2013 Global Compact China Best Practice Case.” In 2014, the company once again received this honor for its practices in “labor employment and rights protection,” demonstrating its visionary approach and proactive efforts on the path of social responsibility. In its introduction of the best practice cases, the Global Compact China Network stated: Developing enterprises in ethnic regions not only faces the challenge of a weak industrial foundation but also encounters significant obstacles such as a relative shortage of talent and linguistic and cultural barriers. By continuously leveraging technological innovation to maintain its competitive edge, actively fostering the integration of ethnicities and cultures, and cultivating talent effectively, Qizheng Tibetan Medicine has made valuable attempts to lay a solid foundation for the sustainable development of the enterprise.

　　Feng Ping, Vice President and Board Secretary of Qizheng Tibetan Medicine, introduced that Qizheng Tibetan Medicine has brought modern pharmaceutical concepts, technologies, and equipment to ethnic regions, addressing common key technical challenges in Tibetan medicine production, leading the overall technological upgrade of the industry to meet contemporary consumer demands. By standardizing and enhancing traditional Tibetan medicine quality standards according to modern R&D requirements, conducting clinical validation using modern medical methods, and actively exploring modern marketing models for Tibetan medicine, Qizheng Tibetan Medicine is paving the way for the Tibetan medicine industry to enter the vast mainland market, thereby creating and commercializing value.

　　Qizheng Tibetan Medicine’s efforts and practices in labor employment and rights protection have also received positive recognition and acclaim from all sectors of society. The company’s Chairwoman, Lei Jufang, has been honored with the title “Outstanding Private Entrepreneur Dedicated to Employee Care.”

　　News Source: Science and Technology Daily

　　Website: http://digitalpaper.stdaily.com/

Lei Jufang: Drug registration regulations do not align with the development of Tibetan medicine.

Qizheng Tibetan Medicine Listed Among the 300 Most Respected Publicly Traded Companies